Tenderwize
Retour à la recherche

Italy – Administrative healthcare services – PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL

IRCCS Istituto Nazionale Tumori·Milano, Italy·EUR 2M·Deadline Nov 24, 2026 · 4 days left·Open·Services
High value
0/100

Score d'opportunité

High riskLow complexity
ServicesOpen
Pourquoi ce score ?

Opportunité

0 / 100

Complexité

0 / 100

Facteurs de risque

Submission deadline in 4 days

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
IRCCS Istituto Nazionale Tumori
Pays
Italie
CPV
75122000 - Administrative healthcare services
Date limite
Nov 24, 2026
Valeur estimée
EUR 2M

Analyse IA de l'appel d'offres

Tenderwize prépare une analyse IA de cet appel d'offres à partir de l'avis TED et des documents de consultation : périmètre, exigences clés, critères de sélection, risques et questions à poser à l'acheteur. L'analyse est générée à l'ouverture de l'appel d'offres.

Acheteur

Localisation

Milano, ITA

Identifiant

80018230153

Activité

Health

Lots (1)

LOT-0001

PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL

PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL PREVISTA CLAUSOLA DI ADESIONE EX-POST A FAVORE DEGLI ENTI DEL CONSORZIO COMPRESA LA FONDAZIONE DEL 300%, COME DA ART. 2 DEL DISCIPLINARE DI GARA

ServicesEU fundedElectronic submission

EUR 2M

Valeur estimée

Durée

Nov 2026 - Nov 2026

Catégorie

Administrative healthcare services

Détails de la procédure

Date de publication
03 Nov 2026
Langues
Italian

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
766672-2026

Documents (1)

Appels d'offres similaires

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy